Comprehensive Hematology Oncology
Clinical research site in St. Petersburg, Florida · Comprehensive Hematology Oncology, 5000 Park St N #1017, St. Petersburg, FL 33709 · (833) 421-0312 · Website
Part of Comprehensive Hematology Oncology
As of July 2026, 11 paid clinical trials are recruiting at Comprehensive Hematology Oncology in St. Petersburg, Florida. Active studies at this site cover conditions such as Carcinoma, Non-Small-Cell Lung, Brain Metastases From HER2 and Breast Cancer and Brain Metastases From Solid Tumors. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Comprehensive Hematology Oncology (11)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
More research sites in St. Petersburg
- Johns Hopkins All Children's Hospital (57 trials)
- Florida Cancer Specialists - North (10 trials)
- Retina Vitreous Associates of Florida (8 trials)
- Saint Anthony's Hospital Cancer Care Center (7 trials)
- All Children's Hospital (5 trials)
- Florida Cancer Specialists (3 trials)
- Florida Cancer Specialists North Region (3 trials)
- GCP Research (3 trials)
- GSK Investigational Site (3 trials)
- Global Clinical Professionals (3 trials)
Explore more
Paid clinical trials in St. Petersburg, FL · Florida clinical trials